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ABSTRACT
Birth is initiated by a programmed inflammatory response of the placenta and amniotic
fluid carried out by maternal and fetal signals, between 37-42 weeks gestation for
human females and 320-340 days gestation for mares. When the inflammatory
response occurs prematurely, pre-term birth is initiated. Pre-term birth is most
commonly associated with a maternal infection that consequently leads to infection of
the placenta and amniotic fluid; however, the terms of infection are unclear, as
microbiota has been discovered in placental membranes and amniotic fluid of healthy
pregnancies. The objective of this study is to challenge the sterile womb hypothesis and
investigate the relationship between microbiota and negative pregnancy outcomes,
specifically pre-term birth. Blood, oral, fecal, uterine, and vaginal samples were
collected from 58 postparturient mares by attending veterinarians at Hagyard Equine
Institute in Lexington, KY, within 24-36 hours of foaling and before uterine
lavage/infusion. Expected due date and date of delivery was noted for birth
categorization as either pre-term or full-term. A foal is considered pre-term if born prior
to 320 days gestation. Microbiota samples were prepared on sterile nasopharyngeal
swabs, which were then used for 16S rRNA gene sequencing on Illumina MiSeq.
Sequencing output was analyzed using QIIME 1.9 on VirtualBox. The abundance of
Fusobacteria, across all samples, in mares that delivered pre-term (PT) was 2-fold higher
than those who delivered full-term (FT). Moreover, Fusobacteria comprised 15% of PT
vaginal samples in comparison to 4.9% FT vaginal. Nearly identical ratios are observed in
uterine samples of PT and FT deliveries (15.5% and 4.4% respectively). Fusobacteria is a
v

common, nonpathogenic microbe of the oral cavity but can cause periodontitis in the
case of overgrowth. Fusobacteria can also lead to negative pregnancy outcomes if
transferred hematogenously through the placenta. However, this is not the case in the
PT deliveries of this study, as Fusobacteria did not comprise even one percent of both
oral and blood samples. On the other hand, Fusobacteria has been reported in the
vaginal microbiome of negative reproductive health and pregnancy outcomes, such as
bacterial vaginosis and pre-term births. These results support the hypothesis that
vaginal microbiota may vertically ascend through the cervix and into the uterine cavity
to proliferate and colonize. We suggest a cross talk occurring between vaginal
microbiota and the uterine environment. Whether this interaction always leads to
negative outcomes is unclear, although the inflammation of the placenta and amniotic
fluid in response to such microbes may be a consequence of their uncontrolled
proliferation.

Key words: microbiome, microbiota, vaginal, uterus, pre-term, birth, reproduction,
equine
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CHAPTER 1
INTRODUCTION

Up until the early 2000s, health and disease had been primarily attributed to
two major factors: genetics and environment. Understanding the human genome has
and continues to be a crucial part of research science in discovering complex
mechanisms that drive each system and how alterations to the genome, whether by
random mutation or epigenetically driven, can lead to disease development. There
was, however, an important component of the human body that was being ignored:
the microbiota. Though its presence was known, not much thought had been given to
the nonpathogenic microorganisms that inhabit every living animal.
Symbiotic relationships have been a driving force of evolution and species
survival. Such relationships, in which all of the organisms involved benefit, is said to be
mutualistic. The Oxpecker bird lands on rhinos or zebras and eats parasites living on
their skin, in exchange for safe transportation. Bees aid in pollination of flowers when
collecting nectar, from which they make food, leaving behind pollen from other
flowers. However, perhaps the most complex and least understood of these is
between the mammalian body and its “normal flora”, which live on and inside the
body, and perform a variety of functions beneficial to mammals. These taxa of
bacteria are a variety of different phyla, an estimated 10-100 trillion microbial cells
that inhabit mucosal and epithelial areas of the body such as the gastrointestinal (GI)
tract, skin, mouth, vagina, urogenital tract, and respiratory tract. These resident,
commensal microbes are termed microbiota [1].
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In 2001, Joshua Lederburg coined the term ‘microbiome’, to describe the
genetic catalog of communal microbiota and its ecological relationship with the host
[2]. Included in its definition are bacteria, yeast, fungi, and viruses, though this thesis
will focus solely on bacterial microbiota [1, 2]. Since the launch of the National
Institute of Health’s (NIH) Human Microbiome Project (HMP) in 2008, research
scientists have uncovered a plethora of evidence in association with the role of
microbiota in health and disease. It has become clear that when microbiota are
undisturbed in their desired niche, they perform beneficial functions for the host in
exchange for nutrients and other components for survival. However, when these
populations are disturbed and no longer in homeostasis with the host, overall health is
often compromised.
In 2008, the NIH HMP reported approximate distributions of bacterial
microbiota throughout the body as: 29% GI tract, 26% oral, 21% skin, 14% airways, 9%
urogenital regions, 1% blood, and 0% in the eyes [2]. It was also reported by the
MetaHit Consortium that the gut microbiome alone contains approximately 3.3 million
nonredundant genes [1]. The human genome consists of an estimated 22,000 genes;
therefore, this finding revealed that our own cells are dramatically outnumbered by
the microbial cells on and inside of us, an estimate of a 10:1 microbe-host cell ratio [1,
3]. This means that for every single cell belonging to the host, there are 10 microbial
cells, suggesting that we are actually 10% human and 90% microbial ecosystem. Since
the microbial cells outnumber the host cells, humans must have evolved mechanisms
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for dealing with such large populations of microbes to prevent their destruction by the
immune system [4].
Several evolutionary theories have developed in regard to host-microbiota
symbiosis. Foster et al. describes the host microbiome as an, ‘ecosystem on a leash,’
meaning that humans have developed mechanisms that allow them to keep
microbiota under favorable conditions while keeping proliferation rates controlled [4].
First, the review discusses the problem with a diverse microbiota: natural selection will
favor microbes that proliferate at rapid rates and will select against those that
replicate slowly, regardless of the benefit that the slower-growing microbe may bring
to the host. This suggests that, from an evolutionary theory perspective, microbes that
invest in their own reproductive fitness outcompete those that do not. Therefore, it
cannot rightfully be assumed that the host and microbial communities work together
to benefit one another; rather, it is more reasonable to infer that the outcome of our
health is dependent on the microbes that survive under selective pressures [4]. This
may explain why particular microbiome characterizations correlate with particular
disease states. Even with this information, it is still observed that the microbiota
predominantly contains beneficial microbes, giving rise to the theory that the host
possesses monitoring and targeting mechanisms as a means of providing its own
selective pressure [4]. Given these two opposing theories, it remains unclear whether
natural selection or host monitoring is the ultimate decision maker in choosing which
microbes survive.

3

Throughout this thesis, the following topics will be discussed in regard to
microbiota: functions, niche preferences, and interactions with the host. Outlined
interactions with the host will primarily focus on those of the female reproductive
tract, although gut microbiota functions are briefly reviewed as these microbes have
proven to play a substantial role in overall health. Though much has been discovered
about the microbiome’s influence on human health, we have merely scratched the
surface of the topic. Considering the ratio of microbiome DNA to host DNA, it is
reasonable to suggest that until we understand the microbiome, we cannot fully
understand the human genome [1].
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CHAPTER 2
BACKGROUND

2.1 The Gut Microbiome
2.1.1 Overview
More than a quarter of our resident microbiome resides within the
gastrointestinal tract, which is a key reason for why this particular area has been given
a lot of attention in microbiome research. Gut microbes are known to aid in nutrient
absorption and modulation of the immune response. Within the past decade, studies
have suggested these microbes are responsible for the overall health of an individual,
proposing new potential interactions with every system in the body. In support of this,
it has been demonstrated that when the continual flux of gut microbiota is disrupted,
disease susceptibility increases. These diseases range from cancers, autoimmune
disorders, cardiovascular diseases, metabolic syndromes, to endocrine disorders.
Although this study focuses on microbe-female reproductive interactions, it is
important to note and appreciate the diversity of the functions of the gut microbiota,
as it plays a significant role on reproductive health.
2.1.2 Nutrient Absorption and Immunomodulation
The large intestine (colon) is an ideal environment for anaerobes, both obligate
and facultative [4]. Bacteria that reside here predominantly undergo anaerobic
respiration and carry out fermentation, which is useful in the breakdown of
indigestible carbohydrates, such as cellulose and pectin, into short fatty-acid chains [5].
These short fatty-acid chains can be metabolized as precursors for cholesterol
5

synthesis, utilized in the liver for gluconeogenesis, lipogenesis, and protein synthesis,
and contribute to 3-9% of overall energy requirements of humans. Few microbial
communities can be found in the stomach and small intestine due to the bactericidal
activity of gastric acid [5]. However, as of 2009, the presence of Lactobacillus,
Veilonella, and Helicobacter has been reported in the stomach at approximately 10 1
cells/gram of stomach contents [6]. Moving along the GI tract, abundance and diversity
increase greatly. The duodenum contains approximately 103 cells/gram, the jejunum
104 cells/gram, and the ileum 107 cells/gram. In addition, the colon contains an
estimated 1012 cells/gram. Although the composition and abundance of gut microbes
fluctuates daily, there are certain phyla that remain fairly consistent. Bacteroidetes
and Firmicutes are the predominant phyla (particularly in the large intestine), with
smaller proportions of Proteobacteria, Actinobacteria, Cyanobacteria, Fusobacteria,
Tenericutes, and Verrucomicrobia [6, 7]. When observing beyond the phylum level,
variation in microbial communities increases. It is speculated that due to functional
redundancy, different microbes capable of performing the same functions across phyla
allow for variation on the genus and species level [7].
Bacterial populations differ greatly between mucosal/epithelial layers and the
intestinal lumen. For example, commonly reported microbiota present in the mucosal
and epithelial areas includes Clostridium, Lactobacillus, and Enterococcus, whereas
typical microbiota of the intestinal lumen includes Bacteroides, Bifidobacterium,
Streptococcus, Enterobacteriaceae, Enterococcus, Clostridium, Lactobacillus, and
Ruminococcus [6]. Approximately 1-3 genera are shared between these areas.
6

Variation between intestinal environments is primarily due to the differing functions of
the stomach, small intestine, and colon, as well as their divergent structures, which
corresponds to the metabolic requirements of the residing microbiota [6].
Factors such as diet, antibiotic use, infection, sexual contact, and stress can
lead to alterations of gut microbiota [5-7]. However, there are particular circumstances
in which some factors do not have a significant affect. For instance, diet does not seem
to influence composition or abundance of microbiota in pregnant women.
Proteobacteria and Actinobacteria have been demonstrated to increase in the gut
microbiome of pregnant women despite decrease in overall richness, which is defined
as the number of different species in an ecological community [5]. During pregnancy,
estrogen levels remain high in contrast to non-pregnant women, in which estrogen
and progesterone levels peak then decrease at different periods of the menstrual
cycle. This suggests that hormones may play a role in the regulation of microbial
communities, or conversely. Furthermore, particular situations such as pregnancy, may
lead to hormone interactions with microbes that outcompete that of dietary effects.
Pregnancy, however, is the only circumstance known to date in which reduced dietary
effects on gut microbiota composition have been observed. Several studies have
produced a germ-free mouse model without metabolic defects that become obese
after transfer of microbiota from obese mice [8-10]. Furthermore, when gut microbes
of lean mice are transferred to obese mice, obesity is resolved, thus supporting the
hypothesis that gut microbiota plays a role in maintaining a healthy body weight unless
present in the wrong proportions. This means that certain gut microbes have differing
7

functions that affect the host inversely. For instance, Bacteroidetes are more efficient
in lipid metabolism, whereas Firmicutes are not. A higher abundance of Firmicutes in
ratio to Bacteroidetes has been associated with increased fat deposition and body
weight, placing greater importance on proper nutrition that appeals to the individual’s
GI microbiota that inclines an individual toward a healthy weight [8, 9].
Commensal microbes are able to inhabit their host without causing disease
pathogenesis because they are recognized by the host as nonthreatening, meaning the
host has tolerance for microbiota. Gut microbiota, in particular, are able to enhance
the innate immune response. Intestinal epithelial cells (IECs) and Paneth cells provide a
barrier function by physically confining commensal and pathogenic microbes to the
intestinal lumen [11]. Paneth cells prodyce additional immune responses by secretion
of antimicrobial peptides (AMPs) and expression of nucleotide-binding oligomerization
domain-containing protein 2 (NOD2), which initiates innate immune signaling in
response to the cytosolic peptidoglycan fragment, muramyl dipeptide (MDP).
Microbiota in the intestinal lumen can upregulate Paneth cell immune responses by
activating Toll-like receptors (TLRs) on IECs and Paneth cells, inducing Reg3γ
expression. Reg3γ is an islet-derived C-type lectin that is bactericidal against Grampositive bacteria [11]. Furthermore, innate lymphoid cells enhance this function of gut
microbiota through the production of the cytokine interleukin-22 (IL-22). IL-22
promotes IEC growth and Reg3γ expression. Additionally, microbiota-derived MDP can
activate NOD2 on Paneth cells, which stimulates production of a subset of AMPs called
defensins. Defensins function in host defense with activity against bacteria, fungi, and
8

many viruses [11]. Additional immune functions of gut microbiota include
development of Foxp3+ T regulatory cells, stimulation of secretory IgA from mucosal
plasma cells, shaping of gut associated lymphoid tissue (GALT), and stimulation of the
immunomodulatory action of macrophages of the intestinal lamina propria [7].
2.1.3 Dysbiosis and Disease
Gut dysbiosis, a complete shift in whole populations of gut microbiota, has
been associated with several diseases and conditions, including atherosclerosis,
hypertension, obesity, colitis, Alzheimer’s disease, and even psychiatric disorders [1216]. Dysbiosis of the gut microbiota can be influenced by several factors, such as the
use of broad-spectrum antibiotics, disease in which inflammation of the GI tract
occurs, and poor nutrition [5, 14]. Interestingly, gut dysbiosis has been associated with
disorders that alter reproductive functionality; the most commonly associated
reproductive disorder being polycystic ovary syndrome (PCOS) [5]. As of 2016, the
estimated prevalence of women diagnosed with PCOS was approximately 15% of
women worldwide, making it the most common endocrine disorder for females [17].
This disorder is characterized by hyperandrogenemia (excess androgen production),
obesity, insulin resistance, irregular menstrual cycles, and ovaries that develop
multiple cysts. These cysts are categorized as either physiological (follicular and luteal
cysts) or pathological (ovarian tumors) [18, 19]. Association between gut dysbiosis and
PCOS suggests that a hormone imbalance may alter GI microbiota composition, or that
the GI microbiota composition may cause a hormone imbalance.
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Physiological cysts are solid or fluid-filled pockets in the ovary that typically
become inflamed. Formation of cysts is most commonly a consequence of a follicle’s
failure to reach maturity, resulting in the inability to release an oocyte- termed
‘anovulation’ [18]. It is common for a physiological ovarian cyst to occasionally
develop, but it is usually not life-threatening and resolves on its own. However, in
women with PCOS, physiological cysts form with nearly every menstrual cycle, halting
menstrual flow from occurring. This also makes it difficult, or impossible in some cases,
for the female to reproduce successfully. A frequently observed secondary outcome of
PCOS is endometriosis, which is the abnormal growth of endometrial cells outside of
the uterus, most commonly on other organs within the pelvis [18]. Endometriosis can
be life-threatening and dramatically decreases the individual’s fertility. In both cases, it
has been shown that the gut microbiota becomes altered, though it is unclear as to
which circumstance is the cause and which is the effect [17, 19].
Gut microbiome alterations have been investigated in PCOS mouse models,
which is achieved by administration of letrozole. Letrozole is a nonsteroidal aromatase
inhibitor, preventing cleavage of testosterone into estrone; therefore, estradiol levels
are reduced [17]. Kelley et al. reported that letrozole treatment resulted in decreased
species abundance and decreased alpha and beta diversity (diversity within a sample
and between sample types, respectively). They also observed that after one week of
letrozole treatment, a shift in the gut microbiome occurs, largely effecting
Bacteroidetes and Firmicutes. Given these results, it was concluded that steroid
hormones might regulate the gut microbiome as aromatase activity has not yet been
10

described in bacteria. Since it was an aromatase inhibitor that was used, it was
determined that PCOS leads to gut dysbiosis and not the other way around. Since this
study was the first to demonstrate a hormone interaction with gut microbiota by
manipulating endogenous testosterone, further studies are required to support or
refute the conclusion that PCOS is the cause and gut dysbiosis is the effect [17]. An
alternative explanation to consider is that either circumstance can occur first, leading
to the other in a bidirectional manner.
In a study conducted by Lindheim et al., gut microbiome composition and
barrier functions of the gut in 24 PCOS-diagnosed females with reproductive and
metabolic defects were compared to that of 19 healthy women [19]. They discovered
that the phyla Tenericutes and Bacteroidetes were significantly lower in stool samples
of PCOS subjects and were associated with reproductive defects. Furthermore, their
results revealed that, in some cases, gut barrier dysfunction and endotoxemia
contribute to metabolic defects observed in PCOS patients. Similarly to the study by
Kelly et al., they were unable to determine if gut dysbiosis lead to PCOS development
or vice versa [19]. It may be useful to induce gut dysbiosis in a mouse model and
monitor for any reproductive abnormalities that result. In addition, if PCOS
development is not observed in these mice with gut dysbiosis, letrozole-induction of
PCOS could be administered to observe how an already altered gut microbiome
influences the severity of PCOS reproductive and metabolic defects.
In conclusion, the resident microbes of the GI tract play key roles in
carbohydrate and lipid metabolism, nutrient absorption, immunomodulation, and
11

maintenance of the overall health of the body. It appears that in order for the health
of the body to be maintained, the gut microbiota composition must be undisturbed.
When composition is altered by any factor previously mentioned, overall health is
compromised and disease susceptibility increases. When studying the microbiota
composition of a particular body site, it is important to consider the gut microbiome as
well, as it may have influence over the site of interest.
2.2 Organization and Functions of the Female Reproductive Tract
2.2.1 Overview
The female reproductive system is the organization of both internal sex organs
and external genitalia that function in concert with one another. The progression of
follicular development to ovulation and menstruation, or pregnancy, is generally well
understood; however, little is known about how the microbiome influences pregnancy
outcomes. The lack of knowledge is primarily as to whether the amnion, defined as the
innermost membrane within the uterus that encloses the embryo/fetus, is truly a
sterile environment. If the amnion is not sterile, what consequences does this bear on
female reproductive health? More specifically, are pregnancy outcomes affected by
the resident microbiota of the host?
2.2.2 Follicular Development: Humans versus Mares
The ovaries carry out two primary functions: gametogenesis and
steroidogenesis [20, 21]. Gametogenesis is defined as the production of gametes,
which is termed oogenesis for females. The term oocyte refers to a gamete in
development and ovum refers to a mature gamete [20]. Steroidogenesis executed by
12

the ovary is the production of the appropriate sex steroid hormones, estrogen and
progesterone [22]. This process occurs in both theca and granulosa cells of the ovary,
which will be discussed later in this section. It is important to note that other
hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH),
are involved in oogenesis; however, it is the pituitary gland that produces and secretes
these hormones [21, 22].
2.2.2.1 Folliculogenesis in Human Females
Ovaries contain structures called follicles, which house the oocyte and undergo
extensive maturation steps influenced by both sex steroid hormones and
gonadotropins until the oocyte develops into an ovum through a process known as
folliculogenesis [21]. Follicle production occurs early in fetal development, as mitotic
divisions increase the number of oogonia, later giving rise to primary oocytes. These
initial follicles are termed primordial follicles and are present at birth where they will
remain in a state of arrest until puberty [21]. There are three developmental states of
ovarian follicles: primordial, growing (further classified into primary and secondary),
and mature/Graafian [20]. The size of the follicle is typically indicative of its
developmental state; however, the change in particular structures associated with the
follicle is key to its identification [20, 21].
Primordial follicle assembly in the ovaries is not dependent on gonadotropin
stimulation, as these follicles are developing during early fetal life, around the third
month of development [21]. Once the ovary has reached maturity, primordial follicles
are stored in the stroma of the cortex, beneath the tunica albuginea, which is the
13

external connective tissue covering the ovaries [20]. Structural changes become
apparent once a primordial follicle becomes a primary follicle, which is identified as
such when the flattened follicular cells surrounding the growing oocyte proliferate and
become cuboidal. It is at this stage that the oocyte’s protective barrier, termed the
zona pellucida, is formed between the oocyte and adjacent follicle cells. The zona
pellucida is an extracellular covering abundant in sulfated acidic glycoproteins (labeled
ZP-1, ZP-2, and ZP-3), which function in spermatozoa binding and induction of the
acrosome reaction, characterized by the release of enzymes to allow a single sperm
cell to penetrate the zona pellucida [20]. The enzymes released in this reaction are
primarily hyaluronidases, which act by catalyzing the degradation of hyaluronan- a
chemical compound found at high concentrations in the extracellular matrix covering a
mature ovum [20, 21].
The cells surrounding the primary oocyte rapidly proliferate into a stratified
epithelium, termed the stratum granulosa [20]. Cells in the stratum granulosa become
granulosa cells; these are the cells in which progesterone production occurs [22]. Two
types of receptors can be found on the granulosa cell: the LH receptor and the FSH
receptor, although FSH receptors are greater in abundance due to continual growth of
the follicle [22, 23]. Due to proliferation of granluosa cells, a connective tissue layer
forms from stromal cells that proximately enclose the follicle. This layer is termed the
theca folliculi, which will further differentiate into the theca interna and theca externa
[20]. Cells within the theca layers are termed theca cells and those within the theca
interna possess a large number of LH receptors [23]. The external layer serves as an
14

outer layer of connective tissue barrier. Until this point, the follicle has been avascular;
however, it is within theca cells that blood vessels begin to appear, which will later
serve as a transportation route for the appropriate hormones. At this stage in
development, the follicle is now classified as a secondary follicle [20].
Progesterone production also occurs in theca cells and is driven by conversion
of ATP to cyclic AMP (cAMP) [22]. The secondary follicle continues to grow in size due
to stimulation by FSH, growth factors, and recruitment of calcium ions until an antrum
forms on one side of the oocyte. Antrum formation is the key characteristic that now
classifies the follicle as a tertiary follicle [20]. Once the antrum becomes a fluid-filled
cavity rich with hyaluronanic acid, termed follicular fluid, the follicle is designated as
mature/Graafian. Upon initiation of ovulation, the Graafian follicle will rupture and
release the oocyte through the oviduct (fallopian tube) by the fimbriae and into the
uterus for fertilization [20]. The ruptured follicle will collapse into deep folds, giving
rise to the corpus luteum, also termed the luteal gland [20, 22]. The theca interna and
granulosa cells become luteal cells by luteinization, which causes the cells to
dramatically increase in size and fill with lipid droplets [23]. Lutein cells within the
corpus luteum establish a highly vascularized network derived from the theca interna
cells. This vasculature will serve as a hormone transportation route for preparing the
endometrium for implantation in the event of fertilization [23]. In the absence of
fertilization and subsequent human chorionic gonadotropin (hCG), the corpus luteum
will degenerate approximately 10-12 days after ovulation [20]. As the corpus luteum
regresses, menstrual flow begins, which is a 3-7 day process. Menstrual flow is the
15

partial shedding of the endometrium’s stratum functionale layer (the portion that
becomes thicker throughout the ovulatory cycle) and bleeding as a result of
destruction of the mucosal vessels [20, 21].
As previously mentioned, gonadotropins released from the anterior pituitary
drive the follicles in both the growth/follicular phase and the luteal phase (Figure B1).
During the follicular phase, FSH carries out two main functions: follicle growth and
stimulation of estradiol production [22]. To begin this process, FSH will bind to FSH
receptors on granulosa cells. Activation of FSH receptors causes rapid proliferation of
granulosa cells for follicle growth. These new granulosa cells will express the enzyme
aromatase, which is responsible for cleaving testosterone into estradiol. The source of
testosterone comes from theca cells [22, 23]. Upon stimulation of LH receptors by LH,
LDL will enter the cell and be used to synthesize pregnenolone followed by
progesterone. Progesterone is chiefly responsible for preparing the internal sex organs
for pregnancy, specifically the uterus, by stimulating secretory changes in the
endometrium [22]. Progesterone can also be converted to 17-OH-Progesterone, which
is then converted to androstenedione, the precursor to testosterone.
Androstenedione can be readily cleaved by either aromatase or 17β-hydroxysteroid
dehydrogenase (HSD). Cleavage by aromatase produces conversion to estrone, then to
estradiol by 17β-HSD [22, 23]. On the other hand, cleavage of androstenedione by
17β-HSD causes conversion to testosterone, which will translocate to granulosa cells
through the basement membrane to be cleaved by aromatase into estradiol. Estradiol
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plays a key role in sexual maturation, meaning it is responsible for development of
female sex characteristics such as breast development, and follicular maturation [22].
Aside from aiding in estradiol production, LH also plays a role in ovulation and
choosing the dominant mature follicle [23]. During the midpoint of ovulation, a surge
of LH will migrate to the follicle that has the most LH receptors expressed on the
surface of theca cells, ultimately choosing it to achieve full maturation [24]. This surge
of LH will signal luteinization of granulosa and theca interna cells, which will transition
the follicle from the follicular phase to luteal. The luteal phase starts at day 14 of the
menstrual cycle when ovulation is complete. It is during this phase that estrogen levels
decrease sharply and progesterone dominates. This increase in progesterone is what
leads to a thickening of the stratum functionale. The source of progesterone comes
from granulosa lutein and theca lutein cells of the corpus luteum [24].

Figure B1. The Human Female Menstrual Cycle. Divided into two phases: follicular and luteal. The
follicular phase occurs during days 4-14 and involves the maturation of an ovarian follicle until oocyte
release (ovulation). During the follicular phase, estrogen and FSH are the dominant hormones. The
luteal phase (days 12-14), is characterized by a surge of LH and signals the final maturation into a
Graafian follicle and release of oocyte at ovulation. The corpus luteum develops and primarily produces
progesterone to thicken the endometrium for possible implantation. (From: Encyclopedia Brittanica, Inc.
2008). Source(s): Clayton, S. G. Menstruation (2018), https://www.britannica.com/science/menstruation

17

It is important to note that during follicular development, several follicles are
developing simultaneously within the ovary. It is the surge of LH at mid-ovulation that
chooses which follicle will release its mature oocyte [24]. The remaining follicles will
undergo atresia, a process mediated by apoptosis of granulosa cells [20]. Primordial
and primary atretic follicles will shrink and eventually disappear after repeated
apoptosis. Large, growing atretic follicles degenerate in the same fashion; however, if
they contain a mature oocyte, the oocyte itself will be delayed in its destruction as it is
no longer sensitive to atresia stimuli of the follicle. Once menstruation has reached
completion, primordial follicles will repeat the process of follicular development.
Unlike males, females have a predetermined gamete quantity, approximately 400
oocytes [20]. When this reserve is depleted, the female will no longer ovulate and
menstruate, marking the stage of menopause [25].
2.2.2.2 Folliculogenesis in Mares
Like human females, follicular and oocyte development occurs in early fetal life
and is independent of gonadotropin stimulation [26]. During this period, at
approximately 70 days of gestation, primordial germ cells proliferate and meiotically
divide until around 150 days of gestation, when they are arrested in prophase I as
primary oocytes. At this time, oocytes are developing into primordial follicles, which
will occur throughout fetal life so that thousands of follicles are present within the
ovaries upon birth. The period in which primary oocytes proliferate, divide, arrest, and
subsequently develop into primordial follicles is termed the preantral stage [26].
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For mares, there are four classifications of follicular development: primordial,
primary, secondary, and antral [26]. Primordial, primary, and secondary follicles
develop during the preantral stage. Maturation of a primordial follicle to a primary
follicle is initiated by the proliferation of somatic cells surrounding the primordial
follicles, similar to when flattened follicular cells surrounding primordial follicles, in
humans, proliferate and become cuboidal, marking the transition of the follicles from
primordial to primary. Proliferation of surrounding somatic cells occurs during postnatal life, stimulated either by atresia or a surge of LH. Classification of primary and
secondary follicles is solely based on size, with a 0.1mm diameter categorized as
primary and 0.2mm classified as secondary [26].
Developing follicles enter the antral stage upon formation of an antrum, which
occurs when the follicles are approximately 0.3mm in diameter [27]. Once antral
follicles reach a diameter of 2mm, their growth and the subsequent selection of a
dominant follicle is determined through follicular waves, which are under the systemic
control of gonadotropins and the local control of insulin-like growth factor-1 (IGF-1),
sex steroid hormones (estrogen and progesterone), inhibins, activins, and vascular
endothelial growth factor (VEGF) [26]. Follicular waves are defined as the simultaneous
development of several growing follicles at a common growth rate, which is typically 23 mm in diameter per day and occurs during estrus. Follicular waves are categorized as
either major or minor waves [27]. Minor waves are characterized by smaller,
subordinate follicles (< 30mm diameter) in the absence of a dominant follicle. Minor
waves occur outside of breeding season to ensure the mare undergoes anovulatory
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estrous cycles [26, 27]. Major waves produce a dominant ovulatory follicle, with 1-2
waves (primary and secondary) occurring around the middle of the estrous cycle [26].
IGF-1 initiates deviation of the dominant follicle by upregulating other growth factors,
which in turn will lead to increased diameter of the follicle that has the most receptors
for the growth factors, meaning it binds more ligand than the other follicles and will,
therefore, become the dominant ovulatory follicle. A unique characteristic of the mare
estrous cycle is that ovulation occurs at high levels of progesterone [26]. This differs
from that of human female ovulation, which occurs in the presence of high estrogen
concentrations.
2.2.3 The Estrous Cycle Varies Between Mammals
In humans, the process of follicular development, ovulation, and subsequent
shedding is termed menstruation. In other mammals, such as mares, baboons, and
mice, this cycle is termed the estrous cycle [28]. As this study involves reproduction in
mares, it is important to understand the differences in cycles between humans and
horses, and a commonly used laboratory model- the CD1 female mouse. For most
mammals, such as the mouse and the baboon, there are four stages of the estrous
cycle, from primary follicle development to shedding of the endometrial mucosal layer:
metestrus, diestrus, proestrus, and estrus [28].
In mice, metestrus defines the period in which the primary follicle is
undergoing changes to become a secondary follicle and is influenced by a rise in
progesterone levels. During diestrus, the primary follicle has matured into the
secondary follicle and progesterone levels decrease as estrogen production increases.
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Proestrus is the complete maturation into a Graafian follicle, as estrogen levels sharply
decrease and progesterone dominates for a brief period. It is at this stage that
ovulation occurs, which occurs on day four or five [28]. Upon absence of fertilization of
the ova, the corpus luteum regresses and the lining of the endometrium begins to
shed, beginning the final stage of estrus. Estrus is characterized by a sharp increase in
estrogen during the dark cycle (night time) and a return to basal levels in the morning
as estrus reaches completion. It is important to distinguish between estrous cycle and
estrus; estrous cycle refers to the complete menstrual cycle, whereas estrus refers to
menstruation (endometrial mucosal layer shedding). In humans, menstruation
normally lasts 3-7 days; however, this is quite short-lived for a mouse, as shedding only
lasts for approximately 12-hours [28]. Defining menstruation changes when discussing
the estrous cycle of the mare.
The mare is described as a polyestrous mammal, meaning it undergoes
ovulatory estrous cycles seasonally [27]. The mare experiences ovulatory estrous
cycles during a particular season in contrast to monthly repetition for humans and
weekly repetitions for mice. Seasonal breeding is a selective pressure that acts to
prevent the mare from delivering during harsh, cold weather [29]. Ovulatory estrous
cycles occur during the months of May to October, lasting approximately 22 days each,
with 5-7 days of this period being in estrus, during the spring and summer breeding
season. A feature of the mare’s estrous cycle that makes it unique from the human
and mouse is that it is positively phototropic, meaning that it is directly initiated and
controlled by the photoperiod, particularly during long days [27]. Seasonal breeding is
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determined by the duration of exposed light (i.e. the length of days), dividing the
estrous cycle into four phases: spring transition period, ovulatory/breeding period,
autumn transition period, and winter anestrus.
The increased exposure of light during the transition from winter to spring
marks the end of winter anestrus and the beginning of the spring transition period,
which will last approximately 2 months. The mare’s pineal gland is stimulated by the
release of serotonin due to nerve impulses generated from light captured by
photoreceptors on the retina [27]. Increased exposure to light during spring and
summer leads to a decrease in melatonin production, signaling the release of GnRH
from the hypothalamus to the adenohyphosis, most commonly referred to as the
anterior pituitary; here, FSH and LH are produced and then discharged to the ovaries
[27, 29]. During this period FSH levels dominate and the production of LH, inhibin,
insulin-like growth factor, and estradiol-17β (E2) are deficient, preventing the
formation of preovulatory follicles [27]. Inhibin, and E2 work together to induce
negative feedback on FSH; however, in low concentrations, negative feedback is
inhibited, allowing FSH to remain in high concentrations. Due to the lack of LH
synthesis, there is no production of a dominant follicle, resulting in the simultaneous
regression of the minor follicular waves. Minor follicular waves are only produced
during the spring transition period, with many non-ovulatory follicles developed,
ranging from 6-21 mm in diameter [27].
The estrous cycle of a mare is defined as the period between two consecutive
ovulations; this lasts approximately 18-22 days. Unlike other mammals, the mare’s
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estrous cycle is divided into two stages: estrus (follicular phase) and diestrus (luteal
phase) [27]. During the follicular phase, estrogen, luteinizing hormone, and inhibin
levels peak, whereas, progesterone, FSH, and prostaglandin F2 (PGF2) levels remain
at baseline levels (Figure B2). Estrus refers to the period in which the mare is in ‘heat,’
meaning she is sexually receptive to the stallion’s genitals and is ready to receive and
transport sperm for fertilization of the oocyte. Estrus lasts approximately 5-7 days, and
the rise in estrogen- in particular, the peak at around day 5- influences sexual behavior
in the mare [27]. As mentioned previously, the increasing levels of inhibin and
luteinizing hormones, which peak between days 5-7 of estrus, are responsible for
deviation of the dominant follicle and atresia of subordinate follicles. Once deviation
of a dominant follicle reaches completion, ovulation occurs and estrogen levels return
to baseline while progesterone levels rise, marking the beginning of diestrus [27]. Once
the dominant follicle ruptures and releases the mature oocyte, estrogen levels rise to
the same level as that of progesterone, to aid in formation and maturation of the
corpus luteum, which functions in the same ways as that of the human female. In the
absence of implantation, the corpus luteum regresses and menstruation occurs in the
final days of diestrus [27]. Mare menstruation differs from that in human females as
mares do not bleed during this period. Instead, they absorb their endometrial slough
and may also excrete it, which is advantageous to mares as bleeding may attract
predators [29].
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Figure B2. The Mare Estrous Cycle. Divided into two phases: estrus and diestrus. Estrus occurs
between day 1-7 and is characterized by secondary follicular waves up until the deviation of a
dominant follicle. During this period, estrogen levels are high and progesterone is low. Ovulation
marks the beginning of diestrus, in which progesterone levels rise and will continue to remain
high until the corpus luteum regress (around day 13), while estrogen returns to baseline. In the
final days of diestrus, primary follicular waves occur and estrogen slow increases as
progesterone decreases Source(s): Journal of Steroids & Hormonal Science 2013). Source: Saute,
K. & Gardon, J. C. A review of the estrous cycle and the neuroendocrine mechanisms in the
mare. J Steroids Horm Sci 4(115), 1-8, doi:10.4172/2157-7536.1000115 (2013).

2.2.4 The Uterus, Placenta, Vagina, and Microbiota: Implications in Pregnancy
The uterus has one major responsibility: to provide a suitable, secure
environment for a fetus throughout development until delivery, usually 37-40 weeks
of gestation for humans and 320-340 days of gestation for mares [29, 30]. For human
females, the uterus is prepared throughout menstruation for implantation of an
embryo by increasing the thickness of the endometrial layer [20]. If implantation is
successful, the thick endometrium will remain until after delivery and the placenta will
24

begin to develop [20]. The placenta is a temporary organ made up of both maternal
and fetal tissues, derived from maternal endometrium and the fetal chorionic sac [31].
Chorion cells within the placenta will produce hCG and other luteotropins to allow the
corpus luteum to remain [20, 31]. By maintaining the luteal gland, estrogen and
progesterone will continue production and prevent degeneration of the endometrium
[31].
The placenta functions as the region for nutrient and gas exchange between
mother and fetus, while also providing blood supply to fetal circulation [31]. The
function of nutrient and gas exchange is carried out by syncytium, a fused
multinucleate trophoblast layer on the surface of the villi within the intervillous space
[32]. The syncytium is also responsible for protecting the fetus from blood-borne
pathogens, though how it does so is poorly understand [32]. It is important to note
that this structure, the syncytium, is present in human females; however, placental
structure varies greatly between mammals. Although the placenta of pregnant mares
is diffuse and cotyledonary like that of human females, the presence of syncytium has
not been reported [33, 34]. In a non-pregnant woman, the cervical canal acts in
conjunction with the uterine peristaltic pump for sperm transport [35]. During
pregnancy the cervical mucus plug forms, which acts as a permeability barrier to limit
passage of potentially pathogenic bacteria from the vagina [35, 36]. Recent studies
have indicated that the cervical mucus plug may not be completely impermeable to
ascending bacteria from the vagina and, with help from the uterine peristaltic pump,
may allow transport of bacteria into the intrauterine cavity [35, 36].
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Until recently, it was thought that the upper female reproductive tract did not
possess a microbiome; however, we now know that one component, the uterus, does.
Studies that have subjected endometrial tissue isolates to 16S rRNA gene sequencing
in women with and/or without uterine abnormalities have identified distinct microbial
communities [37, 38]. Verstraelen et al. harvested endometrial tissue and mucus of
nineteen women without uterine abnormalities [37]. They targeted the 16S rRNA gene
hypervariable V1-2 region by barcoded Illumina MiSeq paired-end sequencing and
found 15 bacterial phyla that were present in all samples. Furthermore, it has been
shown that this uterine microbiome persists during pregnancy [30]. These findings
have led the field of microbiome research to question the widely accepted sterile
womb hypothesis, which holds that the fetus develops within a sterile amnion. To
ascertain that the amnion is sterile is also to assume that the placenta is naturally free
of microbes and that microbes present within placental structures occur as a result of
infection. An additional assumption of this hypothesis is that the fetus will not be
exposed to maternal microbiota until passage through the birth canal [30].
These ideas have been challenged, however, since 1927, when Harris and
Brown discovered bacteria in the amniotic fluid of cesarean section deliveries. This
discovery provided strong evidence that vaginal deliveries may not be the newborn’s
initial exposure to microbes [30]. Doyle et. al conducted a study in 2014, in which they
determined that microbial communities were present in placental membranes
regardless of mode of delivery [39]. In addition, the authors correlated certain
microbial communities with pre-term births and others with full-term births. This study
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revealed a greater relative abundance of the Enterobacteriaceae family and the genera
Fusobacterium, Streptococcus, Mycoplasma, Aerococcus, Gardnerella, and Ureaplasma
in the pre-term samples, most of which are found in the vaginal microbiota of
individuals with bacterial vaginosis. It was also noted that these communities were
absent in the full term (FT) placentas. Furthermore, they discovered that bacteria were
present in all placentas of both vaginal and caesarean births, supporting the idea that
the fetus is exposed to microbiota prior to delivery [39]. Doyle et. al describes that
labor is initiated by a scheduled inflammatory response in both the placenta and
amniotic fluid, which is influenced by maternal and fetal signals. Based on this
description, an unscheduled inflammatory response is defined as pre-term birth (PTB)
initiation [39].
PTB can be classified as either very pre-term (V-PTB) or just pre-term. V-PTB,
for humans, is defined as delivery prior to/at 28-weeks gestation and PTB is defined as
delivery between 28-32 weeks gestation [30]. For mares, PTB is defined as delivery
prior to 320 days gestation [34]. A common cause of PTB is infection, either exogenous
or endogenous, which is subsequently able to pass the placental membrane and infect
the fetus [30]. In fact, 90% of PTB cases in mammals are due to an infectious agent that
causes severe inflammation of the placenta and amniotic fluid (placentitis and
amnionitis) [30, 39]. In 2013, Stout et. al hypothesized that negative pregnancy
outcomes may arise from bacterial communities residing in the maternal basal plate of
the placenta. The results revealed Gram positive and negative intracellular bacteria in
27% of placental basal plates with a significant association in pre-term births [40].
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However, bacterial communities residing in the placenta may not always be indicative
of placentitis. A study conducted by Queiros da Mota et al. observed that 28 out of 73
culture-positive placenta samples were positive in the presence of chorioamnionitis
(intra-amniotic infection) and the remaining 45 cases did not, indicating that microbial
communities in the placenta are less likely a consequence of an infectious agent and
that microbiota may naturally transfer to the placenta during pregnancy to perform
beneficial functions [41]. Aagaard et al. characterized 320 placental microbiome
samples of healthy pregnancies and found that the most common microbes are
Firmicutes, Tenericutes, Proteobacteria, Bacteroides, and Fusobacteria [42]. The
results imply that the placenta might possess microbiota that are transient colonizers
and that bacteria within the placenta may not always lead to negative pregnancy
outcomes.
In contrast to the sterile womb hypothesis, Perez-Munoz et al. proposed that
the infant gut microbiome is established in utero via hematogenous transfer of
maternal oral and gut microbiota [43]. The sterile womb hypothesis argues that the gut
microbiome of vaginally delivered babies resembles the maternal vaginal microbiome
and C-section babies have gut microbiota similar to that of the maternal skin
microbiota. In contrast, the in-utero colonization hypothesis states that maternal oral
and gut microbes hematogenously transfer to the placenta throughout gestation.
These microbes are subsequently transferred to the fetus via the umbilical cord, where
they will begin initial colonization before birth [43]. This proposal was derived from
results of studies in which microbiota found in placental membranes and amniotic fluid
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were also found in the oral cavity and colon, some of which had no associated
pregnancy complications and others linked with negative pregnancy outcomes such as
PTB and miscarriage [44-46].
To investigate how the microbiome of the uterus impacts health of
pregnancies, Moore et. al compared uterus samples of virgin and pregnant heifers
[47]. In uteri of both virgin and pregnant heifers, three phyla were found in similar
abundance: Bacteroidetes, Firmicutes, and Proteobacteria, which also happen to be
common phyla of the GI tract across a majority of mammalian species. In addition, the
investigators discovered that the same microbes present in the virgin and pregnant
uteri are also microbes associated with post-partum uterine disease, a common cause
of infertility in cattle due to pathogenic bacteria persisting in the uterus after delivery.
Based on these results, Moore et. al hypothesized that post-partum uterine disease is
most likely a result of the overgrowth of resident microbes upon pregnancy and the
heifers’ immune response to the overgrowth. Overall, Moore et. al concluded that a
resident microbiome of the uterus is established by the time of reproductive maturity
[47]. Consistent with this study and several others, microbial communities found in the
uterus are also present in the vagina and gut. Therefore, Moore et al. proposed that
microbiota from the vagina and cervix migrate via intrauterine ascension, where they
will subsequently colonize the uterus. The investigators also concluded that the
uterine microbiome is maintained in a quiescent state in the virgin and pregnant
uterus until influenced by events, in which mechanisms utilized by the body to
maintain microbiota composition are disrupted [47]. The results of this study suggest
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that negative pregnancy outcomes may be a result of the loss of ability for the host to
keep resident microbiota under controlled growth.
Much of the literature that encompasses uterine microbiome studies also focus
on the vaginal microbiome of only pregnant subjects, non-pregnant subjects, or both.
Due to discoveries of similarities between the uterine and vaginal microbiome, it
stands to reason that microbes present in the vagina should be considered when
investigating the microbiome’s influence on the uterus and pregnancy. This is
especially true when considering the vertical ascension route of vaginal microbiota to
the uterus during sexual maturity and/or to the amnion during pregnancy. A general
consensus among vaginal microbiome studies is that, in comparison to the GI tract, the
vagina is low in biodiversity in terms of both alpha- and beta diversity [48, 49]. These
studies are also in agreement that a healthy vaginal microbiome is comprised mostly
of Lactobacillus (approximately 20 species reported) and is dominated by one to two
of the four most common Lactobacilli species: L. crispatus, L. gasseri, L. iners, and L.
jensenii [49, 50]. It is hypothesized that Lactobacilli protect the vagina from
colonization by pathogenic microorganisms through the production of lactic acid, and
by outcompeting them for nutrients and epithelial cell receptors [49]. There are
circumstances, such as bacterial vaginosis (a polymicrobial disease due to bacterial
overgrowth in the vagina) and the variation of vaginal microbiota composition in
women of different geographical locations, in which Lactobacilli are in smaller
abundance and anaerobic bacteria dominate [49]. The most common anaerobes
reported under these circumstances are Prevotella, Megasphaera, Gardnerella
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vaginalis, Sneathia, and Atopbium vaginae. Nevertheless, composition of vaginal
microbiota is subject to change, depending on hormonal changes, age, sexual activity,
and overall reproductive health [49, 50].
Once pregnancy is established, it is observed that the individual’s vaginal
microbiome composition is more stable and less diverse [49]. This is primarily
attributed to the dominance of estrogen; therefore, hormone fluctuation is
dramatically decreased [51, 52]. It is also noted that the presence of anaerobes in the
vagina decrease during the time of gestation. The rise of estrogen may favor
Lactobacilli survival as this results in increased vaginal glycogen deposition [49].
Though the vaginal microbiome composition tends to remain constant throughout
pregnancy, as mentioned previously, the gut microbiome changes frequently,
independent of diet. The most commonly reported bacterial species colonizing the
vagina in association with PTB deliveries are Ureaplasma urealyticum, Mycoplasma
hominis, Bacteroides spp., Gardnerella vaginalis, and Fusobacterium nucleatum [49,
50]. As mentioned previously, defects in the cervical mucus plug play a key role in the
intrauterine ascension of vaginal bacteria.
After reviewing the literature, we are left with three main questions regarding
the uterine microbiome: (1) Is the amnion exposed to microbiota? If so, in what stage
of pregnancy is this exposure initiated and why? (2) Why and how does the host
maintain a resident uterine microbiome upon pregnancy? (3) How do these resident
microbes benefit the host prior to reproduction, and what is their influence on both
mother and fetus during pregnancy? The host-microbe interactions with female
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reproductive organs is still far from understood; additional studies are required to
confirm that the uterus houses its own unique microbiota, as well as what this implies
with pregnancy and female reproductive health.
2.2.5 Objectives of Study
Although associations have been established between microbiota and
pregnancy outcomes, what is left to understand about how microbiota effects
pregnancy greatly outweighs what is known to date. The objective of this study is to
investigate the intrinsic differences between the oral and reproductive microbial
environments of post parturient mares who either foaled at or before full term. In
addition, we seek to further understand the relationship between microbiota and
pregnancy outcomes, more specifically, pre-term birth. We hypothesized that either a
lack or large abundance of a particular phylum/phyla of bacteria in the uterus will be
observed in the mares of our equine model who deliver pre-term. Furthermore, we
assume that this lack/presence of microbiota associated with pre-term births will
either not be present or present in small quantities of the uteri in mares who deliver at
full-term.
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CHAPTER 3
EXPERIMENTAL METHODS
3.1.1 Equine Model and Sample Collection
Surveys were conducted of 58 post parturient (after labor) mares, and their
foals, by attending equine veterinarians from the Hagyard Equine Medical Institute in
Lexington, KY. These surveys included the following information about the mare: name
of mare, date of sample collection, farm in which mare was housed, veterinarian
obtaining samples, date of mare foaling, original expected due date, inquiry of any
antimicrobial treatment within the last month of gestation, location of foaling, and
circumstances of foaling (normal or dystocia and how dystocia was resolved, if
applicable). The following information was gathered about the foal: alive or dead at
birth, whether resuscitation or similar emergency treatment was required at time of
birth, a list of any congenital abnormalities present, presence and severity of flexure
tendon contracture, and a list of other abnormalities present at birth or within the first
24-48 hours. These questions provide sufficient information as to the conditions of the
mare and her foal pre- and post-delivery, which can be used for correlation purposes
during data analysis. The following samples were collected from the mare by the
attending veterinarian within 24-36 hours of foaling and before uterine
lavage/infusion: swab from uterus or cervix, swab from vaginal vault, 2-5 ml of uterine
fluid, blood sample, fecal sample, and oral swab. Upon collection, the samples were
placed in biohazard bags and transported on ice to the Hagyard Laboratory, and
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eventually shipped for sequencing preparation to the Oakley Laboratory at Eastern
Kentucky University in the Department of Biological Sciences.
3.1.2 Sample Preparation and Sequencing
Once samples were received, they were stored in -20°C and -80°C (dependent
on available storage room in either unit). Samples were then organized in order by
their corresponding survey. Each mare was labeled consecutively “Sample #” on
biohazard bag, survey, and appropriate preparation tubes for simplicity. A table and
key were created throughout preparation to ensure proper labeling and identifying
which, if any, specific samples from each mare were not collected at Hagyard for data
analysis for future additional projects. The key is described as follows: B (blood), US
(uterine swab), OS (oral swab), VS (vaginal swab), UF (uterine fluid), and FM (fecal
matter). An ‘X’ was placed under any column in which a sample was not present for
that mare. All microbiome samples were labeled in consecutive numerical order (1332) on preparation tubes and in the table next to the appropriate mare’s name.
Microbiome samples were thawed at room temperature for 30 min-1 hr,
depending on severity of frozen state. Sterile microcentrifuge tubes were labeled
appropriately to sample information in the collection table. All collected swabs (oral,
uterine, and vaginal) were aseptically transferred directly from collection tube to
preparation tube. Blood samples were centrifuged for 5 minutes at 1,300 xg and a
subsequent aliquot of 300μl was placed in the corresponding preparation tube,
followed by a sterile nasopharyngeal swab.
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The aliquot and swab procedure was repeated for the uterine fluid collection,
but these samples were not centrifuged. The aliquot was to serve as a backup in the
event that the amount on the swab was not sufficient for sequencing. Finally, the fecal
collection was prepared last as it takes the longest to thaw and needs to be thawed
completely. Since the external regions of the fecal collection most likely contains
microorganisms that are not present in the mare’s gastrointestinal tract, the collection
was split open and a nasopharyngeal swab was scraped to the inside of the fecal
matter. An additional small amount of the solid sample was isolated using sterile,
disposable tweezers was placed in the preparation tube with the swab, for the same
reason for the fluid aliquots. All prepared samples were stored at -20°C and shipped on
dry ice to the Gilbert Laboratory in Chicago, IL for Illumina MiSeq 16S rRNA gene
sequencing.
3.1.3 Data Analysis
All data analysis of microbiome MiSeq files was executed through QIIME 1.9 on
VirtualBox. Sequence reads were quality filtered (0.5 max errors and 151 trunclen),
dereplicated, filtered of singletons, OTU clustered, filtered of chimeras, and mapped to
OTUs using drive5 usearch 8.1. Greengenes database was used to assign taxonomy and
align sequences with 97% identity. Samples exhibiting counts of ≤ 1.0
sequence/sample was filtered from OTU tables prior to taxa summary. Relative
abundance of taxa was reported in percentages by the summarize_taxa.py python
script in QIIME, which calculates relative abundance by dividing the counts in a
particular OTU by the total number of sequences observed in the sample. Alpha
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diversity nonparametric t-distribution based on 999 Monte Carlo permutations, at a
depth of 180 sequences/sample was executed on the final biom files, as 180 was the
minimum number of counts observed. The Shannon diversity index metric used to
assess alpha diversity. Jack-knifed beta diversity at an even 100 replicates was
executed on final biom files for weighted UniFrac distance matrices, which were used
to make Emperor PCoA plots. Significance for relative abundance of summarized taxa
reported by QIIME was assessed with a Linear Discriminant Analysis (LDA) using LEfSe
(LDA Effect Size), developed by the Huttenhower Lab at Harvard University, on the
web server Galaxy.
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CHAPTER 4
RESULTS

Illumina Miseq output analysis in QIIME reported 2,634,820 sequencing reads,
with the maximum number of OTU counts in a given sample being 24,531. Figure 1
shows relative abundance of a phyla summary across all sample types. A greater
prevalence, in similar amounts, of Fusobacteria is detected in vaginal, uterine swab,
and uterine fluid samples in comparison to the others (4.9%, 8.6%, and 8.2%,
respectively). Figure 2 shows the same phyla summary categorized by term, showing
an increase in Fusobacteria in PT samples in comparison to FT samples (6.1% vs 3.1%).
To investigate the relationship between PT samples and increased Fusobacteria
prevalence, genus summaries and corresponding proportions were produced for each
sample type and term (Figures 3-8). PT uterine swabs share 12 genera with PT vaginal
swabs (Figure 9), 12 genera with PT uterine fluid samples (Figure 10), 7 genera with PT
oral swabs (Figure 11), 10 genera with PT blood samples (Figure 12), and 3 genera with
PT fecal samples (Figure 13). FT uterine swabs share 14 genera with FT vaginal swabs
(Figure 9), 14 genera with FT uterine fluid samples (Figure 10), 8 genera with oral
swabs (Figure 11), 9 genera with FT blood samples (Figure 12), and 2 genera with FT
fecal samples (Figure 13).
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Figure 1. Phyla Summary Across All Samples by Sample Type. Phyla summary across all samples based on 97% identity on Greengenes taxonomy
database. The same phyla are present in each sample, with the exception of Chloroflexi, Synergistes, and Spirochaetes. A greater abundance of
Fusobacteria is detected in uterine, vaginal, and uterine fluid (8.2%, 8.6%, and 4.9% respectively. Fecal samples appear to be more diverse in
comparison to other samples.
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Figure 2. Phyla Summary Across All Samples by Term. The same phyla are present in pre-term (PT) and full-term (FT) samples, with
the exception of Chloroflexi and Synergistes. A greater abundance of Fusobacteria is detected in PT samples versus FT samples.
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Figure 3. Genera Summary of Uterine Swabs by Term. A) Complete relative abundance summary of genera identified in FT (left) and PT (right),
of which share 13 out of 19 (68%) reported genera. Largest observable differences in abundance of shared genera is in Fusobacterium (1.6%
and 14.48%) and Staphylococcus (8.37% and 2.69%). B) Relative abundance with differences removed (Granulicatella, Gemella, Micrococcus,
Bacteroides, Corynebacterium, RFP12 family, Haemophilus, Acinetobacter, Citrobacter, Leptotrichiaceae family, Lachnospiraceae family, and
Clostridium).

A
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Figure 3 (Continued)
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Figure 4. Genera Summary of Vaginal Swabs by Term. A) Complete relative abundance summary of genera identified in FT (left) and PT
(right), of which share 14 out of 19 (74%) reported genera. Largest observable differences in abundance of shared genera is in
Fusobacterium (4.42% and 13.83%) and Enterobacteriaceae family (7.56% and 2.26%). B) Relative abundance with differences removed
(Enterococcus, Prevotella, Bacteroidetes phylum, Unassigned: Other, Acinetobacter, Campylobacter, Leptotrichiaceae family, and
Helococcus).

A

43

B
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Figure 5. Genera Summary of Uterine Fluid by Term. A) Complete relative abundance summary of genera identified in FT (left) and PT (right), of
which share 13 out of 19 (68%) reported genera. Largest observable differences in abundance of shared genera is in Fusobacterium (2.43% and
8.30%) and Staphylococcus (7.72% and 1.50%). B) Relative abundance with differences removed (Bacteroidales order, RFP12 family, Gemella,
Micrococcus, Corynebacterium, Citrobacter, Ruminococcaceae family, Lachnospiraceae family, Clostridiales order, Helococcus, and
Peptostreptococcaceae family.
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Figure 6. Genera Summary of Oral Swabs by Term. A) Complete relative abundance summary of genera identified in FT (left) and PT (right), of
which share 16 out of 19 (84%) reported genera. Largest observable differences in abundance of shared genera is in Streptophyta order (5.83%
and 9.83%). B) Relative abundance with differences removed (Fusobacterium, Psychrobacter, Rothia, Acinetobacter, and Pasteruellaceae family).
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Figure 7. Genera Summary of Blood Collection by Term. A) Complete relative abundance summary of genera identified in FT (left) and PT (right), of
which share 15 out of 19 (79%) reported genera. Relative abundance is approximately the same between FT and PT (no large observable
differences). B) Relative abundance with differences removed (Arthrobacter, Microbacterium, Acinetobacter, Actinobacillus, Oxalobacteriaceae
family, Ruminococcaceae family, and Gemella).
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Figure 8. Genera Summary of Fecal Collection by Term. A) Complete relative abundance summary of genera identified in FT (left) and PT (right), of
which share 17 out of 19 (89%) reported genera. Relative abundance is approximately the same between FT and PT (no large observable differences). B)
Relative abundance with differences removed (Paraprevotellaceae Prevotella, Paraprevotellaceae family unknown genus, Acinetobacter, and
Neisseria).
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Figure 9. Genera Summary of Uterine and Vaginal Swabs by Term. A) Relative abundance summary of shared genera identified in FT samples (14
out of 19, 74%). B) Relative abundance summary of shared genera identified in PT samples (12 out of 19, 63%). Fusobacterium abundance is much
higher in PT uterine and vaginal swabs in comparison to FT (14.48% and 13.83% PT vs. 1.6 and 4.42% FT. Clostridium is present in FT samples but
is not present (< 0.5%) in PT.

A

53

B

Figure 9 (Continued)

54

Figure 10. Genera Summary of Uterine Swab and Uterine Fluid by Term. A) Relative abundance summary of shared genera identified in FT
samples (14 out of 19, 74%). B) Relative abundance summary of shared genera identified in PT samples (12 out of 19, 63%). Fusobacterium
abundance is much higher in PT uterine swab and vaginal uterine fluid in comparison to FT (14.48% and 8.30% PT vs. 1.6 and 2.43% FT).
Clostridium is present in FT samples but is not present (< 0.5%) in PT. Gemella is present in PT samples but is not present (< 0.5%) in FT samples.
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Figure 11. Genera Summary of Uterine Swab and Oral Swab by Term. A) Relative abundance summary of shared genera identified in FT
samples (8 out of 19, 42%). B) Relative abundance summary of shared genera identified in PT samples (7 out of 19, 37%). Fusobacterium
abundance is reported at low relative abundance in FT uterine swab and oral swab samples (1.6% and 3.44%) and is not present (< 0.5%) in
PT. Gemella is present in PT samples, primarily dominant in the oral swabs, but is not present (< 0.5%) in either FT samples.
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Figure 12. Genera Summary of Uterine Swab and Blood Collection by Term. A) Relative abundance summary of shared genera identified in FT
samples (9 out of 19, 47%). B) Relative abundance summary of shared genera identified in PT samples (10 out of 19, 53%). Gemella is present in
PT samples but is not present (< 0.5%) in FT samples. Most reported genera (except Actinobacillus, Gemella, and Enterococcus) are not similar in
terms of abundance percentage in both FT and PT samples.
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Figure 13. Genera Summary of Uterine Swab and Fecal Collection by Term. A) Relative abundance summary of shared genera identified in FT
samples (3 out of 19, 16%). B) Relative abundance summary of shared genera identified in PT samples (3 out of 19, 16%). Uterine swabs (FT and PT)
are most dissimilar to fecal collection (FT and PT).
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Figure 13 (Continued)

Alpha diversity was assessed by the Shannon Diversity Index for consistency
purposes to ensure that the diversity reported in each sample is consistent with that of
the literature. Diversity is highest within cecum and blood samples, and lower in the
remaining sample types (Figure 14). P < 0.05 (fecal and blood vs uterine fluid, vaginal,
oral, and uterine swabs), P > 0.05 (fecal vs blood), and P = 1.0 (oral swabs vs. uterine
fluid, vaginal, and uterine swab samples). Weighted jackknifed beta diversity at an
even 100 replicates is represented in PCoA plots by sample type and term (Figures 15
and 16).

Figure 14. Shannon Diversity Index by Sample Type. Diversity (abundance and evenness) is highest
within the fecal and blood samples. Diversity within oral swabs are not significantly different from
that of uterine fluid, vaginal swabs, and uterine swabs. P-values for fecal samples= 0.015 against
uterine fluid, vaginal, oral, and uterine swabs; 0.09 against blood samples. P-values for blood= 0.015
against uterine fluid, vaginal, oral, and uterine swabs. P-values for oral swabs= 1.0 against uterine
fluid, vaginal, and uterine swab samples.
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Figure 15. PCoA Plot Representation of Weighted Jackknifed Beta
Diversity by Sample Type. Fecal samples have greater variance
(diversity) of OTUs but fewer OTUs are shared between other sample
types. Vaginal, uterine, and uterine fluid samples exhibit a clustering
pattern (shared OTU abundance) as variance within these samples
increases. Oral swabs and blood have lower variance but share OTUs
with all other sample types.

Figure 16. PCoA Plot Representation of Weighted Jackknifed Beta
Diversity by Term. The same clustering patterns as seen in Figure 5,
represented by term. The middle of the plot is representative of FT
and PT points (OTUs) that have differing variance and do not exhibit a
strong clustering pattern. The points are primarily vaginal, uterine
scrape, and uterine fluid (refer to Figure 15).
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LEfSe reported significantly abundant genus between FT and PT uterine swab
samples (Figure 17). Significant abundant features reported for PT uterine swab:
Fusobacterium, Gemella, Unassigned (genus designated as ‘Other’), Granulicatella,
Geothrix, RFN20, 41B, RF16, Exiguobacterium, Actinomycetales order (genus
unknown), Peptostreptococcus, Desulfovibrio, Mobiluncus, Cyanobacteria phylum
(genus designated as ‘Other’), Clostridiales order (genus designated as ‘Other’), and
Rhodocyclaceae family. Assigned approximate LDA scores for each feature is as follows
(respective to reported PT list): 4.5, 3.7, 3.7, 3.5, 3.5, 3.3, 3.2, 3.2, 3.1, 3.0, 2.9, 2.8, 2.7,
2.7, and 2.6. Significant abundant features reported for FT uterine swab:
Lachnospiraceae family (genus designated as ‘Other’), Rhizobiaceae family,
Lachnospiraceae family (genus unknown), and Rathyibacter. Assigned approximate
LDA scores for each feature is as follows (respective to reported FT list): 2.5, 2.6, 2.7,
and 3.5. Note that Figure 17 shows negative values for the assigned LDA scores for FT
abundance. This is because of the order of the numerator and denominator, which is
determined alphabetically, when calculating effect size; therefore, absolute values can
be used when interpreting the scale of the logarithmic LDA score.
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Figure 17. LEfSe Significance Analysis of Uterine Swab Relative Abundance by Term. Significantly abundant features are reported
in descending order of abundance significance between PT and FT uterine swab samples. Most significantly abundant features for
PT (LDA score ≥ 3): Fusobacterium, Gemella, Unassigned, Granulicatella, Geothrix, RFN20, 41B, RF16, Actinomycetales, and
Peptostreptococcus. Most significantly abundant feature for FT: Lachnospiraceae family.

CHAPTER 5
DISCUSSION

5.1.1 Discussion Overview
Composition and proportion of bacteria detected in uterine swab and uterine
fluid samples strongly overlaps with vaginal swab samples, supporting the vertical
ascension route of vaginal microbiota through the cervix and to the uterus. A
noticeable increase in prevalence of the phylum Fusobacteria is observed in uterine
swab, uterine fluid, and vaginal samples, as well as in PT samples versus FT samples.
Further assessment of this difference on a genus level reveals the highest abundance
of Fusobacterium in uterine swab, vaginal swab, and uterine fluid PT samples.
Interestingly, an inverse relationship is observed between the abundance of
Clostridium and Fusobacterium. For instance, in FT uterine swab samples, Clostridium
makes up approximately 8.41% of the overall genus composition, while Fusobacterium
comprises approximately 1.6%. Meanwhile, in PT uterine swab samples, Clostridium is
detected to be at less than 0.5%, explaining why there is not a designated spot for it on
the pie chart; however, Fusobacterium was calculated to make up approximately
14.48% of the overall composition. A similar trend is seen in FT/PT uterine fluid and
vaginal swab samples. In previous studies, Clostridium is typically associated with
negative pregnancy outcomes such as pre-term birth or even fetal death, across
several models (human, swine, mice, etc.). In this study, it appears that Clostridium
may provide a protective effect by outcompeting pathogenic microbes, such as
Fusobacterium, unintentionally keeping the growth of these organisms in check.
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Hematogenous transfer of organisms from other body sites, across the
placenta, cannot be completely ruled out in this study. Although uterine swab samples
shared fewer groups with blood samples (approximately 10), the genus Gemella is only
detected in PT uterine swab, uterine fluid, blood, and oral swab samples with greatest
abundance in the oral swabs (23.5%). It is important to note that the causative agents
of periodontal disease that have also been isolated in the placenta, reside in the
subgingival spaces of the mouth. In this study, those microbes were likely not isolated
due to method of sample collection. The oral swab collection consisted of a swab of
the buccal regions, not between the subgingival spaces. Therefore, it is possible that
Gemella sp. in the oral cavity, and even the Fusobacterium sp. detected in the uterine
swab/fluid samples, transferred via blood vessels in the gums and across the placental
membrane. The only genus that was detected in the PT uterine swab samples that was
not shared/detected with any other sample type was Granulicatella at a small relative
abundance of 1.75%.
An LDA reported markedly different results than the relative abundance
reports. According to this analysis, Clostridium is not significantly abundant in FT
uterine swab samples over PT uterine swab samples, and several taxa are reported to
be significant in PT uterine swab samples that were not reported in the relative
abundance charts. What is consistent between the reported LDA of summarized taxa
and relative abundance is the abundance of Fusobacterium, Gemella, and
Granulicatella being significantly more abundant in PT uterine swab samples compared
to FT, with the largest score assigned to Fusobacterium, consistent with the reported
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relative abundance. Clostridium, Fusobacterium, Gemella, and Granulicatella will be
described throughout the remainder of this chapter to assess mechanisms behind how
these microorganisms influence pregnancy outcomes. Furthermore, possible
explanations will be explored for why Fusobacterium was reported at low relative
abundance in the oral genus summaries.
5.1.2 Fusobacterium: Mechanisms of Pathogenesis
The phylum Fusobacteria consists of a group of gram-negative, non-spore
forming, obligate anaerobes that typically inhabit the oral cavity as a commensal; in
fact, Fusobacteria species are one of the most frequently detected bacteria in both
healthy and diseased oral cavities [53, 54]. Furthermore, the genus Fusobacterium is
the second most recurrently isolated anaerobic bacteria in human and animal
microbiota [55]. Fusobacteria, more specifically Fusobacterium nucleatum, has been
identified as a causative agent of most periodontal disease cases and has been
associated with negative pregnancy outcomes (still birth, preterm birth, spontaneous
abortion, and early-onset neonatal sepsis), GI disorders, skin ulcers, Lemierre’s
syndrome, etc. [53-58]. F. nucleatum is the most commonly identified Fusobacterium
sp. in a wide variety of diseases due to the virulence factors it possesses. F. nucleatum
has the abilities to coaggregate with other species to enhance disease progression and
invade a variety of mammalian cells and host molecules via adhesins [53-55]. Adhesins
are surface proteins that function in the attachment of bacterial cells to specific hostcell receptors/substrates or, in some cases of F. nucleatum pathogenesis, to salivary
macromolecules, immunoglobulin G, and extracellular matrix proteins [53, 55]. F.
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nucleatum has a tropism for several cell types including epithelial and endothelial cells,
polymorphonuclear leukocytes, natural killer (NK) cells, erythrocytes, fibroblasts, and
monocytes [53, 55].
F. nucleatum’s ability to coaggregate with other bacteria is one of the reasons
why it is often detected in mixed-community infections [55]. It does so by recognizing
surface molecules on other species either by adhesins (Fap2, RadD, and aid1) or other
outer membrane proteins (OMPs) [53, 54]. Coaggregation of F. nucleatum with other
species of bacteria is the key first step to plaque formation in the oral cavity, usually in
the subgingival spaces. The adhesin and invasin identified as FadA is the most wellstudied F. nucleatum virulence factor [59]. FadA becomes an active complex (FadAc)
when its two forms bind to one another, intact pre-FadA and secreted mature FadA
(mFadA), of which is an absolute requirement for F. nucleatum to bind to and invade
host cells [53]. FadAc attaches to cadherins, which are calcium-dependent adhesion
molecules responsible for forming adherens junctions to bind host cells together [59].
Another well-studied virulence factor of F. nucleatum is Fap2, abbreviated for
fusobacterial apoptosis protein [54]. In a 2015 study conducted by CoppenhagenGlazer et. al, the authors characterized Fap2 as a galactose-inhibitable adhesin after
observing the inhibition of hemagglutination (a mode of attachment conserved across
many pathogens) in a strain of F. nucleatum by the addition of D-galactose, showing
that Fap2 is galactose-sensitive/inhibitable. Furthermore, Coppenhagen-Glazer et. al
discovered that Fap2 also plays a role in coaggregation after noting that three
hemagglutination-deficient mutant F. nucleatum strains failed to coaggregate with
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Porphyromonas gingivalis but retained coaggregation ability with Streptococcus
sanguins. To observe the role of Fap2 in placental colonization of F. nucleatum, since
FadA had been previously described as the only major virulence factor in adverse
pregnancy outcomes, the investigators injected wild-type F. nucleatum and the
hemagglutination-deficient mutant strain into the tail veins of CD1 female mice. They
observed that the Fap2 mutant strain reduced placental colonization of F. nucleatum
2-fold [54].
The most frequently reported method by which Fusobacterium results in
negative pregnancy outcomes is by hematogenous transfer from the oral cavity in
pregnant women with periodontitis [53-55]. In 2004, Han et. al studied the effects of
dental bacteremia, induced by F. nucleatum, on pregnancy outcomes. Seventy-two
hours after injecting F. nucleatum into the tail vein of pregnant mice, the investigators
observed cases of preterm birth and fetal death at term [60]. In a similar study
conducted by Stockham et. al in 2015, three aims were investigated: 1) determine if
hematogenous transfer of F. nucleatum from the oral cavity to the murine placenta
and subsequent adverse pregnancy outcomes is strain specific, 2) utilize an oral gavage
murine model of periodontitis to observe if increased severity of adverse pregnancy
outcomes is influenced by induced periodontitis, and 3) compare immunological
changes of the induced periodontitis pregnant murine model to intravenous injection
of different F. nucleatum subspecies and correlate these changes to any adverse
pregnancy outcomes that arise. The authors observed that hematogenous transfer
from the oral cavity to the placenta was strain specific as F. nucleatum was the only
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Fusobacterium sp. that colonized the placenta. Furthermore, inducing periodontitis did
not further increase the severity of adverse pregnancy outcomes and there were no
significant immunological changes between pregnant control mice and pregnant
inoculated mice [56].
In this study, we did not observe Fusobacterium reported in relative abundance
of PT oral swabs. but it was reported in similar abundance in PT vaginal swabs.
Fusobacterium has been identified in cases of bacterial vaginosis and urinary tract
infections, which can lead to negative pregnancy outcomes [61]. Interestingly, we
observed a rather high biodiversity in all vaginal swab samples. Although, alpha
diversity was reported as being low in vaginal swabs, several different genera were
identified, which usually is not the case for human females. As discussed in Chapter 3,
Lactobacillus sp. dominates the vaginal microbiome, with some variation, and remains
dominant throughout pregnancy due to increased estrogen levels. Lactobacillus’s role
in creating an acidic pH environment in the vagina exerts protection against obligate
anaerobes by providing an unsuitable environment for their survival. A disruption in
Lactobacillus dominance of the vagina is often the result of bacterial vaginosis [61]. In
both FT and PT vaginal samples of mares, Lactobacillus does not dominate, and
diversity appears to be high- despite the tendency of diversity in the vagina to
decrease during pregnancy. These results, however, have been found to be true for
humans and laboratory mice- mares live in a much different environment and have a
vastly different diet; therefore, it is not surprising to observe a unique diversity in an
equine model in comparison to mouse models and human studies. Due to the lack of
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studies using equine models for microbiota characterization, we do not currently know
what communities constitute a healthy vaginal microbiome for mares; therefore, we
cannot definitively state which organisms are resident microbiota and which are
pathogenic transient colonizers, as we do not have sufficient comparison.
5.1.3 Clostridium: Mode of Competition
Clostridium is a Gram-positive, obligate anaerobe genus under the phylum
Firmicutes [62]. Many Clostridium sp. are responsible for causing serious disease, such
as Clostridium perfringens and gas gangrene, Clostridium difficile and diarrhea,
Clostridium tetani and tetanus, Clostridium botulinum and botulism, and Clostridium
sordellii and toxic shock syndrome in post-partum women [63-67]. On the other hand,
several Clostridium sp. are found to be part of a normal and healthy resident
microbiome [3]. For example, although C. difficile can create infection within the GI
tract, it is also part of the normal gut microbiome in small abundance because other
populations dominate and outcompete it; in fact, C. difficile infections are most
commonly a result of antibiotic-induced gut dysbiosis [11]. Clostridium has also been
identified as part of a normal vaginal microbiome in less than 10% of women;
therefore, it is not entirely unusual to find Clostridium sp. in a healthy woman,
especially since these characterizations vary geographically [5, 30].
Clostridium has the ability to produce antimicrobial peptides (AMPs) termed
bacteriocins [68, 69]. Bacteriocins function to aid the bacterium secreting it in
outcompeting other bacteria similar to it. In essence, Clostridium will sense bacteria
that are in close proximity, of which metabolize the same nutrients as it does for
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survival [69]. All Clostridium sp. ferment butyrate and amino acids serine and
threonine, while others can utilize tryptophan, histidine, arginine, alanine, methionine,
leucine, asparatate, lysine, and/or phenylalanine, suggesting that amino acid
fermentation is strain-specific [70]. All strains of Fusobacterium ferment butyrate and
use glutamate, histidine, and aspartate for energy metabolism. In addition,
Fusobacterium nucleatum utilizes glutamine and lysine for anaerobic fermentation in
order to produce sufficient energy for glucose transport in the event of intracellular
molecule biosynthesis [55]. Here, we propose that because Clostridium and
Fusobacterium utilize much of the same amino acids for energy metabolism,
Clostridium could potentially secrete bacteriocins to reduce or eliminate the growth of
Fusobacterium in the uterus of a healthy mare. When Clostridium growth is reduced,
possibly due to a dysbiosis in the uterus, Fusobacterium is able to outcompete it,
resulting in placentitis and amnionitis, and eventual PTB. It was noted that Clostridium
was reported in similar proportion in the vaginal swab samples as the uterine swab
and uterine fluid samples. Considering the intrauterine ascension route of vaginal
microbiota, the same relationship proposed between Clostridium and Fusobacterium
could also be occurring in the mare’s vagina.
5.1.4: Gemella and Granulicatella:
Gemella is a gram-positive, obligate anaerobe genus under the phylum
Firmicutes [71]. It is a normal constituent of the oral cavity, upper GI tract, and vaginal
microbiome in select populations [71]. Gemella is not frequently reported as cause for
disease in clinical cases as it is primarily an opportunistic pathogen when mucosal
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membranes are compromised, such as the lung environment in cystic fibrosis patients
[71]. Because it has a preferred niche for mucosal areas, it is not surprising that this
genus of bacteria was found in the uterine fluid, as this sample type is primarily a
collection of the cervical and endometrial mucus. However, Gemella was detected in
PT samples, but not in FT samples, suggesting that this bacterium may not be part of a
microbiome in a healthy mare’s reproductive tract. Additionally, it is important to note
the small relative abundance reported in the uterine fluid and uterine swab samples
because it does not appear to be an overgrowth and therefore, may not be
contributing to the initiation of PTB. Lastly, Granulicatella was previously designated as
nutritionally variant streptococci (NVS), but is now described as ‘streptococci-like’ due
to a few distinct metabolic differences [72]. This bacterium has been described as a
mouth and urogenital tract commensal; in terms of pathogenesis, it rarely causes
disease. Granulicatella sp. has primarily been detected as an opportunistic pathogen in
immunocompromised patients, most commonly causing infective endocarditis in the
elderly, and has been reported in a few pre-term birth cases of mothers diagnosed
with urinary tract infections [72, 73]. This genus is a fastidious, Gram-positive,
facultative anaerobe under the phylum Firmicutes [73]. Much like Gemella,
Granulicatella was detected in small relative abundance, only in the PT uterine swab
samples; therefore, it does not appear to be an overgrowth and is unlikely to have
initiated infection within the pregnant uterus.
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CHAPTER 6
CONCLUSIONS & FUTURE DIRECTIONS

6.1.1 Conclusions
Mares may establish a uterine microbiome from vaginal microbiota during
sexual maturity. In the event of pregnancy, stability in the flux of microbiota
contributes to a healthy pregnancy; however, when these communities are disrupted,
pathogenic microorganisms are able to colonize, proliferate rapidly, and infiltrate
other body sites. In this study, it appears that a reduction in Clostridium populations in
the upper and lower female reproductive tract results in the overgrowth of other
microorganisms, such as Fusobacterium sp. However, this result must be taken with
caution and further analyzed, as a linear discriminant analysis did not report
Clostridium abundance to be significant in FT versus PT uterine swabs. Since the
Lachnospiraceae family (under the Clostridia class) was reported significantly abundant
in FT uterine swab samples with the highest LDA score, it may be more accurate to
hypothesize that Clostridia exert a protective effect in the uterus during pregnancy,
rather than the more narrow, specific identification of the Clostridium genus.
Due to the large increase in Fusobacterium in PT uterine swab and vaginal swab
samples, as well as being reported as the most significantly abundant feature over FT
uterine swabs, we conclude that this microbe is the infectious agent initiating pre-term
birth, though the exact mechanism by which Fusobacterium initiates such an event in
these mares is unknown. Before a correlation can be established between the
relationship of Clostridium sp. and the female reproductive tract of mares, further
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experimentation is required. We have shown here that Fusobacterium can lead to
negative pregnancy outcomes in mares much like in humans and laboratory mouse
models, suggesting that mechanisms of pathogenesis in this bacterium is ubiquitous
across various mammalian species. This study provides evidence against the sterile
womb hypothesis and contributes to the field preliminary results on the influence of
microbiota on pregnancy outcomes in mares. We have characterized the uterine and
vaginal microbiome in post-parturient mares, which has not been done before;
therefore, the results of this study could prove to be useful in the prenatal care of
pregnant mares. There is one study to date that characterized the uterine microbiome
of non-pregnant mares, but only beta diversity is reported, of which shows a moderate
diversity within the uterus [74]. The taxonomy of these microbes is unclear; therefore,
we do not have any baseline comparison for our results.
6.1.2 Future Directions
To continue assessment of the microbiome’s influence on pregnancy outcomes
in an equine model, the previously described methods should be repeated; however, a
routine vaginal and oral swab collection throughout the gestational period may be a
useful additional measure. Observing the vaginal microbiome, throughout pregnancy,
could provide insight into the stability, or instability, of a particular mare’s vaginal
microbial communities and may help predict pregnancy outcomes like pre-term birth.
This is important for the field of equine care because mares that give birth pre-term
one time, tend to carry out a habit of always delivering pre-term and the cause for this
is unknown. Understanding the mechanisms behind this and creating diagnostic
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measures to prevent such negative outcomes could provide a substantial boost for the
advancement of veterinary medicine and the equine industry. Because hematogenous
transfer of microbes has been reported in cases of pre-term birth and fetal death,
routine oral swab and blood collection may also be a useful predictive measure in
conjunction with routine vaginal swab assessment. The oral swab should be a
collection from the subgingival spaces in order to isolate and identify bacteria involved
in dental bacteremia and periodontal disease.
Another problem that needs to be addressed is the lack of knowledge
pertaining to the characterization of the normal, healthy vaginal microbiome in mares.
If possible, repetitive assessment of vaginal swab collections of healthy, non-pregnant
mares could result in a sufficient characterization and could be used for future
comparative analyses. Furthermore, knowing a mare’s vaginal microbiome prior to
pregnancy, could provide insight into potential pregnancy outcomes that particular
mare may be susceptible to, allowing for proper preventative care to be administered.
In closing, although the results of this study are not currently generalizable to humans,
further experimentation with the recommended additions may provide translational
results in the future.
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